KAZIA THERAPEUTICS LTD Logo

KAZIA THERAPEUTICS LTD

Oncology-focused biotech developing targeted therapies for cancers with high unmet needs.

KZIA | US

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
THREE INTERNATIONAL TOWERS LEVEL 24,, 2000 SYDNEY NSW

Description

Kazia Therapeutics Ltd. is an oncology-focused biotechnology company engaged in the development of innovative drugs for cancer. The company's lead program is paxalisib, a small molecule inhibitor of the PI3K/AKT/mTOR pathway designed to cross the blood-brain barrier, which is being investigated for various forms of brain cancer. Its development pipeline also includes EVT801, a selective VEGFR3 inhibitor being studied for its potential to block the growth of blood and lymphatic vessels that support tumor growth. The company focuses on addressing cancers with high unmet medical needs through its portfolio of targeted therapies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2013-07-03 12:11
FORM 6-K
English 26.8 KB
2013-07-02 02:26
CONVERTED BY EDGARWIZ
English 18.4 KB
2013-06-28 03:20
CONVERTED BY EDGARWIZ
English 32.4 KB
2013-06-27 01:33
CONVERTED BY EDGARWIZ
English 24.5 KB
2013-06-11 03:36 English 27.2 KB
2013-06-04 01:48
CONVERTED BY EDGARWIZ
English 18.0 KB
2013-06-04 01:40
CONVERTED BY EDGARWIZ
English 60.8 KB
2013-05-29 12:24
FORM 6-K
English 26.4 KB
2013-05-29 12:12
FORM 6-K
English 39.5 KB
2013-05-23 20:55 English 192.8 KB
2013-05-14 00:48
CONVERTED BY EDGARWIZ
English 7.6 KB
2013-05-07 12:14
FORM 6-K
English 26.6 KB
2013-05-07 12:10
FORM 6-K
English 25.8 KB
2013-05-07 01:43
CONVERTED BY EDGARWIZ
English 25.4 KB
2013-05-02 01:41
CONVERTED BY EDGARWIZ
English 335.3 KB

Automate Your Workflow. Get a real-time feed of all KAZIA THERAPEUTICS LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KAZIA THERAPEUTICS LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KAZIA THERAPEUTICS LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CRONEX.CO.,LTD Logo
A CRO supplying biological species and bio-tissue materials for medical research.
South Korea
215570
C&R Research Inc. Logo
A full-service CRO providing clinical research for pharma and medical device companies.
South Korea
359090
Cte Group Spolka Akcyjna Logo
Diversified firm in HR services, corporate events, and composite materials.
Poland
LPS
curacle co., ltd. Logo
A clinical-stage biopharma developing drugs for intractable vascular diseases.
South Korea
365270
CytoMed Therapeutics Ltd Logo
Clinical-stage developer of off-the-shelf allogeneic cell immunotherapies for cancer.
United States of America
GDTC
Cyxone AB Logo
A clinical-stage biotech developing therapies for autoimmune and autoinflammatory diseases.
Sweden
CYXO
DARWIN AG Logo
Biotechnology firm creating personalized products from individual biological data.
Germany
7V0
DEINOVE Logo
Develops compounds from rare bacteria for cosmetics and new antibiotics.
France
ALDEI
Delta Drone Logo
Develops drone-based systems for the logistics, security, and military sectors.
France
ALDR
Delta-Fly Pharma, Inc. Logo
Biopharmaceutical firm developing novel anticancer drugs from existing components.
Japan
4598

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.